Takeda Pharmaceutical Company Limited Deferred Tax Liabilities
Takeda Pharmaceutical Company Limited (TKPHF) had Deferred Tax Liabilities of JPY 35.15 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Income Taxes
ifrs-full:DeferredTaxLiabilities · last filed 2025-06-25
- 2025-03-31: Deferred Tax Liabilities 35.15B JPY.
- 2024-03-31: Deferred Tax Liabilities 113.78B JPY.
- 2023-03-31: Deferred Tax Liabilities 270.62B JPY.
- 2022-03-31: Deferred Tax Liabilities 451.51B JPY.
| Period end | Deferred Tax Liabilities | Deferred Tax Liabilities as first filed |
|---|---|---|
| 2025-03-31 | 35.15B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 113.78B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 270.62B JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 451.51B JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 542.85B JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 710.15B JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 721.46B JPY 20-F · filed 2020-06-24 | 867.06B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 90.72B JPY 20-F · filed 2019-06-27 |